Drug reference
prednisolone sodium phosphate
Glucocorticoid · Anti-inflammatory; Immunomodulator
GlucocorticoidAnti-inflammatory; Immunomodulator
CDSCO approved
EXCRETION
—
not curated
INTERACTIONS
—
none in our sources
PREGNANCY
—
not curated
Mechanism
Not yet extracted
Indications
allergic conjunctivitis and marginal corneal ulceranterior segment inflammationbacterial conjunctivitischorioretinitiscyclitisendophthalmitis (off-label)Graves’ ophthalmopathyherpes zoster ocular infection (with antiviral therapy)iritisnonspecific and superficial punctate keratitispostoperative ocular inflammationoptic neuritissympathetic ophthalmiadiffuse posterior uveitisvernal keratoconjunctivitiscorneal injury from chemical, radiation, thermal burns; or penetration of foreign objects
Side effects
Serious
- posterior subcapsular cataracts
- secondary infections
- secondary open-angle glaucoma
Related guidelines
Hepatitis B — chronic infection
EASL · Gastroenterology · 2025
Preventive care in inflammatory bowel disease
ACG · Gastroenterology · 2025
Helicobacter pylori infection
ICMR · Gastroenterology · 2021
Inflammatory bowel disease
OTHER · Gastroenterology · 2015
Skin and soft tissue infections
IDSA · Infectious Diseases · 2010
Other Glucocorticoid drugs
Ask House about prednisolone sodium phosphate
Continue into a citation-backed clinical answer with the drug context already attached.
Sources: Goodman & Gilman 14e·Verified: 2026-05-10 · House clinical team